Medibio Ltd
ASX:MEB
Medibio Ltd
Cash from Operating Activities
Medibio Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Medibio Ltd
ASX:MEB
|
Cash from Operating Activities
-AU$932.1k
|
CAGR 3-Years
36%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Mach7 Technologies Ltd
ASX:M7T
|
Cash from Operating Activities
AU$5.1m
|
CAGR 3-Years
151%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
4DMedical Ltd
ASX:4DX
|
Cash from Operating Activities
-AU$25.3m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
CogState Ltd
ASX:CGS
|
Cash from Operating Activities
$490.4k
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Pro Medicus Ltd
ASX:PME
|
Cash from Operating Activities
AU$71.4m
|
CAGR 3-Years
30%
|
CAGR 5-Years
38%
|
CAGR 10-Years
29%
|
|
Medadvisor Ltd
ASX:MDR
|
Cash from Operating Activities
-AU$4.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
See Also
What is Medibio Ltd's Cash from Operating Activities?
Cash from Operating Activities
-932.1k
AUD
Based on the financial report for Jun 30, 2023, Medibio Ltd's Cash from Operating Activities amounts to -932.1k AUD.
What is Medibio Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
40%
Over the last year, the Cash from Operating Activities growth was 44%. The average annual Cash from Operating Activities growth rates for Medibio Ltd have been 36% over the past three years , 40% over the past five years .